Relay Therapeutics, Inc. (RLAY) Tops Q4 EPS by 12c
Tweet
Share
E-mailGet Alerts RLAY Hot Sheet
Join SI Premium – FREE
Relay Therapeutics, Inc. (NASDAQ: RLAY) reported Q4 EPS of ($0.45), $0.12 better than the analyst estimate of ($0.57).
For earnings history and earnings-related data on Relay Therapeutics, Inc. (RLAY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- What Delta’s report tells investors in American and United
- JPMorgan analysts name top short ideas for third quarter 2026
- Asahi loses market share in Japan as weather hits beer demand - UBS
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
